University of California and Elsevier Forge Open-Access Deal

The agreement comes two years after the university system cut ties with the publisher after failing to come to an agreement.

Written byDiana Kwon
| 4 min read
university of california library elsevier scholarly academic publishing journal subscription open access transformative deal contract

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, LUCENTIUS

More than two years after negotiations began, the University of California and the academic publisher Elsevier announced on March 16 that they had finally secured an open-access deal.

“We hope that others will take the message that a research-intensive, high-output institution can, in fact, negotiate and implement an open-access agreement with a major publisher that is affordable and sustainable,” says Ivy Anderson, the associate executive director of the California Digital Library and co-chair of UC’s publisher negotiation team. “It’s a path that we hope others will consider following.”

The agreement comes after a widely publicized split between Elsevier and UC, a network of 10 campuses and the Lawrence Berkeley National Laboratory. After eight months of negotiations with no deal, UC cancelled its subscription to Elsevier in February 2019. Following this move, many academics spoke out in support of UC by stepping down from their positions on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies